Acasti Pharma Welcomes Professor Jacques Genest to Its Scientific Advisory Board

LAVAL, Quebec, July 8, 2010 (GLOBE NEWSWIRE) -- Neptune Technologies & Bioressources Inc. (“Neptune”) (Nasdaq:NEPT) (TSX-V:NTB) and Acasti Pharma Inc. (“Acasti”) are pleased to announce the expansion of Acasti’s Scientific Advisory Board (SAB) by welcoming Pr. Jacques Genest, MD, CM; FRCP(C); FACC; FAHA, to join Pr. Steven Nissen (Cleveland Clinic), Pr. Ruth McPherson, MD, PhD, Pr. William Harris (Sandford Research/USD), Pr. Thomas G. Hartman (Rutgers University Center), and Dr. Magdy M. Abdel-Malik (Quaestio Global Partners).